OTC

Seasoned OTC executives drive growth at independent OTC companies

With the recent OTC industry consolidation and mergers, many seasoned executives have left large OTC companies and moved on to smaller, independent companies where their past experience brings success in a nimbler environment, focused on specific brands and categories. Based on primary research for our soon-to-be published report, OTC Indies: U.S. Analysis of Independent OTC Companies, there are several examples of seasoned OTC executives driving growth at small, independent companies.Continue reading

Sexual Wellness

Healthy Growth Predictions for the Booming Sexual Wellness Market

With more relaxed attitudes about sexuality, there is a proliferation of sexual wellness products in both retail and online stores. Vibrating devices, supplements for sexual enhancement, condoms, and personal lubricants are everywhere. More and more retailers and online sites are embracing consumers’ interest in adult toys. There are increased sections of brick-and-mortar stores devoted to these products while television advertisements for erectile dysfunction (ED) medications air on a regular basis. If marketers are successful in gaining FDA approval for Rx-to-OTC switches of prescription ED medications, this market is poised to see strong double-digit gains over the next few years. ED medications currently sold via prescription that could make the switch to OTC status include Cialis by Eli Lilly/Sanofi, Bayer’s Levitra, and Pfizer’s Viagra. Switch timing, likelihood of approval, impact on the market, and sales forecasts for each of these drugs are analyzed in-depth in our Rx-to-OTC Switch Pipelines USA: Competitive Assessment report.Continue reading